Tianjin
China
3
2020-12-03
3
2021-12-07
These are the the leading inventors for applications assigned to Hemu Wang:
Hemu Wang based in Tianjin, CN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Hepatitis B treatment vaccine base on inactivated whole recombinant Hansenula polymorpha cells which expresses HBsAg and HBcAg
#2 | 2019-07-18 ✅ Patent 10,653,772 granted on 2020-05-19Hepatitis B treatment vaccine on the basis of inactivated, whole recombinant Hansenula polymorpha cells expressing HBsAg
#3 | 2019-03-21 ✅ Patent 10,821,174 granted on 2020-11-03Recombinant Hansenula polymorpha-based high dosage hepatitis B vaccine
Also check out Hemu Wang's (Tianjin, China) applicant profile with 3 patent applications submitted.
572662 ⎘